The role of dynamic contrast material-enhanced magnetic resonance (MR) imaging of the breast as an adjunct to the conventional techniques of mammography and ultrasonography has been established in numerous research studies. MR imaging improves the detection and characterization of primary and recurrent breast cancers and allows evaluation of the response to therapy. The breast imaging lexicon published by the American College of Radiology allows a standardized and consistent description of the morphologic and kinetic characteristics of breast lesions; however, there are many challenges in the interpretation of breast enhancement patterns and kinetics, and many imaging and interpretation pitfalls must be considered. New breast MR imaging techniques that are based on the use of molecular markers of malignancy may help improve lesion characterization. The margin characteristics of a lesion and the intensity of its enhancement at MR imaging 2 minutes or less after contrast material injection are currently considered the most important features for breast lesion diagnosis.
Introduction
Dynamic contrast material-enhanced magnetic resonance (MR) imaging of the breast is increasingly used as an adjunct to mammography and ultrasonography (US) to improve the detection and characterization of primary and recurrent breast cancers and for evaluation of the response to therapy. MR imaging is useful for detecting multifocality and multicentricity of breast cancer; differentiating between scar tissue and recurrent cancer after breast-conserving therapy (1) ; screening patients in high-risk groups (eg, those with the BRCA1 gene) (2) ; examining breasts that contain implants; examining the breasts of patients with histologically proved metastatic breast cancer with unknown primary origin (3) ; and, in patients with a finding of cancer in one breast, screening the contralateral breast for occult cancer (4) . The sensitivity of MR imaging for the detection of breast cancer is very high, with 90% being the value reported in most studies (5, 6) . However, with regard to the detection of ductal carcinoma in situ (DCIS), the sensitivity of MR imaging varies between 40% and 100% (7) . The result may be false-negative in the presence of DCIS or an invasive ductal or lobular malignancy. Specificity of 37%-100% has been reported for breast MR imaging; in most studies, it has varied from 50% to 70% (5) . The relatively low specificity of breast MR imaging is a disadvantage, and rigorous criteria have been proposed for the interpretation of breast MR images (8) . In addition, new imaging techniques based on molecular and cellular properties of tissues have been investigated (9, 10) . The use of computer-assisted methods such as neural network clustering has been proposed to aid in the assessment of contrast enhancement on breast MR images (11) .
The American College of Radiology breast MR imaging lexicon provides a specific standardized vocabulary for describing the morphologic and kinetic characteristics of breast lesions (8) . All suspicious areas are defined as a focus or foci (with a diameter of less than 5 mm), mass (a three-dimensional space-occupying lesion with a convex margin), or nonmass. The description of a mass should include a characterization of its shape (round, oval, lobular, irregular), margin (smooth, irregular, spiculated), and internal enhancement pattern (homogeneous, heterogeneous, rimlike, central, septal). The description of a nonmass lesion should include a characterization of its distribution (focal or multifocal, linear, ductal, segmental, regional, multiregional, diffuse), internal enhancement (homogeneous, heterogeneous, stippled, clumped, reticular), and symmetry. Associated findings such as edema, adenopathy, cysts, and skin and chest wall involvement are reported as well. The kinetic curve assessment involves a description of both the initial peak (slow, medium, rapid) and the delayed phase (persistent, plateau, or washout) of contrast enhancement.
In this article, we discuss the different patterns of enhancement, each of which has a specific meaning with regard to the diagnosis of breast abnormalities. The discussion is based on the results of several research studies in which the predictive value of particular imaging features was investigated during the interpretation of contrastenhanced breast MR images. We also focus on potential diagnostic and technical pitfalls of breast MR imaging and discuss emerging techniques that are aimed at improving lesion characterization with the use of molecular markers of malignancy.
Enhancement Patterns

Lack of Enhancement
The absence of a visible lesion on contrast-enhanced MR images that corresponds to a palpable or mammographically visible abnormality is highly predictive of a benign finding. However, the absence of observed enhancement at breast MR imaging does not exclude in situ or invasive cancer. Many invasive cancers that show no enhancement are small or have a small invasive component (12) . Lack of enhancement has a high negative predictive value (NPV) for malignancy (88%-96%) (12, 13) . Among nonenhancing tumors, about 48% are DCIS (7, 12) , and 52% are invasive carcinomas (12, 13) .
Morphologic Criteria for Benignity
Many benign breast lesions may appear enhanced, including nonproliferative lesions (mild hyperplasia, fibroadenomas), proliferative lesions without atypia (sclerosing adenosis, radial and complexing sclerosing lesions, moderate hyperplasia, intraductal papillomas), and atypical lobular and ductal hyperplasia. The normal breast parenchyma, especially in premenopausal women, also may appear focally enhanced, and this appearance may lead to a false-positive finding (14) .
A typical benign feature for masses is a smooth margin (NPV, 95%). Low-signal-intensity internal septa were demonstrated to be predictive of benignity (NPV, 98%) (13) (Fig 1) . However, Contrast-enhanced T1-weighted fat-saturated gradient-echo (GRE) (repetition time msec/echo time msec, 20/4.5; flip angle, 30°) images from a 51-year-old woman show regional micronodular (Ͻ5 mm stippled or punctate) enhancement in fibrocystic breast tissue (a) and rimlike enhancement around a cyst (arrow in b) within a region of fibrocystic breast tissue. (c) T2-weighted (4000/90) fat-saturated image (same patient as in a and b) shows the cyst (arrow). Comparison of the contrast-enhanced images with the T2-weighted image is important to recognize the benign nature of these findings. (d) Contrast-enhanced T1-weighted GRE (20/4.5; flip angle, 30°) subtraction image from a 44-year-old woman shows an oval mass with smooth and lobular margins and enhancement with dark internal septa, typical of a fibroadenoma (arrow). (e) T2-weighted (4000/90) fat-saturated image (same patient as in d) shows increased signal intensity in the lesion (arrow) in comparison with that seen in d. Increased T2-weighted signal intensity is typical of a myxoid fibroadenoma in a woman of this age. In women older than 50 years, age-related sclerotic changes in fibroadenomas result in a greater prevalence of lesions with fibrotic low signal intensity, which reduces the diagnostic usefulness of the T2-weighted imaging characteristic. recent results of a study by Schnall et al revealed that 47% of malignant lesions were shown to have nonenhancing internal septa (12) . If a mass is lobulated and shows no enhancement or only minimal enhancement, it is likely benign (NPV, 100%) (13) . If a mass is lobulated and shows moderate to marked enhancement (NPV, 67%), further evaluation may be warranted (13) . Correlation between the enhancing portion of the lesion and its T2-weighted signal intensity is helpful (15) . T2-weighted signal hyperintensity in the same portion of the lesion that appears enhanced on T1-weighted images is highly suggestive of benignity, although not all masses with high signal intensity on T2-weighted images are benign. A finding of mild regional nonmass enhancement also is suggestive of a benign abnormality (NPV, 92%).
Morphologic Criteria for Malignancy
The description of the margin of a focal mass is the most predictive feature of the breast MR image interpretation. Irregular or spiculated margins have a positive predictive value (PPV) of 84%-91% (13) (Fig 2) . Rimlike enhancement highly correlates with a cancer diagnosis (PPV, 84%) (12); however, this feature is uncommon, with a prevalence of 16%. Other features associated with malignancy include heterogeneous internal enhancement and enhancing internal septa.
A linear or branching ductal distribution of enhancement is difficult to assess and interobserver agreement is poor, according to a report by the MR imaging lexicon committee (16) , and the reported PPV for this feature has varied from 24% to 85% (5) .
A moderate to marked degree of nonmass regional enhancement has a PPV of 59% (13). Regional enhancement with a micronodular (stippled) pattern was found in both benign (eg, fibrocystic disease) and malignant (eg, DCIS) abnormalities (13) . Stippled enhancement is associated with a low incidence of malignancy (25%), while clumped, heterogeneous, and homogeneous enhancement are associated with a 60%, 53%, and 67% likelihood of cancer, respectively (12). Regional enhancement associated with a focal lesion was shown to have a PPV of 81%; however, this finding has a low prevalence and is seen in only 14% of patients with a focal malignancy. A segmental distribution of enhancement was associated with a 78% likelihood of cancer, while a regional distribution was associated with a 21% likelihood of cancer. Therefore, mild stippled enhancement with a regional distribution is indicative of benignity, whereas segmental or clumped enhancement is more likely to indicate malignancy (12) .
Other Features
T2-weighted Signal Characteristics
T2-weighted signal hyperintensity within the viable (enhancing) portion of the lesion is highly suggestive of benign histology (15) . However, T2-weighted signal intensity is not a reliable predictor of benignity in irregular or spiculated masses. Colloid (mucinous) carcinoma may be manifested as a hyperintense and minimally enhancing mass on T2-weighted images (13, 17) . On T2-weighted images, breast cancers are more likely (87%) to have iso-or hypointense signal, compared to the signal intensity of the normal breast parenchyma (Fig 2) (18) . Hypointense internal septa on T2-weighted images are typical of benign fibroadenomas (Fig 1) . Rarely, adenoid cystic carcinoma may contain low-signal-intensity septa that are nonenhanced (13) .
The assessment of lesions on T2-weighted images is most helpful in younger patients. Myxoid fibroadenomas in young women typically demonstrate increased T2-weighted signal intensity. However, there are age-related sclerotic changes in fibroadenomas in older women, and the greater prevalence of fibrotic low-signal-intensity fibroadenomas in women older than 50 years reduces the diagnostic value of the T2-weighted signal intensity criterion (18) . Sclerotic fibroadenomas may have the same hypointense appearance as wellcircumscribed breast cancers. However, with the progression of fibrosis, the enhancement rate of fibroadenomas decreases. Thus, the primary diagnostic criterion of enhancement may be used to avoid unnecessary referral for biopsy. Medullary cancers tend to occur in younger women and may have a circumscribed appearance. The signal intensity of the lesion on T2-weighted images may not aid in the differential diagnosis of myxoid fibroadenoma and medullary cancer. For these reasons, the T2-weighted signal intensity of a breast lesion is used as a secondary criterion, to confirm a diagnosis of benignity established on the basis of morphologic features (the primary criterion), and not to rule out breast cancer.
Focal Perilesional Edema
A focal area of hyperintense T2-weighted signal near a lesion is highly suggestive of malignancy. The signal intensity increase is thought to be related to increased capillary permeability in the presence of tumor-related angiogenesis (15) .
Architectural Distortion
An architectural distortion that is nonenhanced may represent a radial scar; if enhanced, it is highly suggestive of invasive cancer. Desmoplastic tethering (the hook sign) has been described as highly indicative of a malignancy in an untreated breast (15) . This feature, which is thought to represent invasion of the Cooper ligaments in the direction of the pectoral muscle, is best evaluated on T2-weighted images. The hook sign is not observed in the presence of noninvasive cancers.
Skin Thickening and Edema
Skin thickening and edema in an untreated breast on MR images, as on mammograms, may be signs of malignancy, especially of inflammatory carcinoma. In a treated breast, these features are frequently observed after radiation therapy.
Lymph Nodes
The lack of visibility or the subtle visibility of axillary lymph nodes is almost as commonly associated with benign lesions as with malignant ones. Therefore, the absence of adenopathy does not help differentiate benignity from malignancy. In contrast, nodes with a diameter of more than 1 cm are more common in malignant cases (15) . In addition, a loss of the fatty hilum of the lymph node is suggestive of malignant involvement. 
Enhancement Kinetics
Breast lesion enhancement can be characterized qualitatively by assessing the enhancement kinetics curve obtained by plotting the signal intensity values in breast tissue intensity over time after contrast material injection. These curves show both the initial slope of increasing enhancement, from the baseline value to the peak, and the subsequent trend. Three enhancement patterns can be identified on the basis of the signal intensitytime curve.
Type I is a pattern of progressive enhancement, with a continuous increase in signal intensity on each successive contrast-enhanced image (Fig 3) . This enhancement pattern is usually associated with a benign finding (83% benign, 9% malignant) (19) . Its sensitivity and specificity for indication of a benign lesion are 52.2% and 71%, respectively (6) . However, Schnall et al reported that readers in a multi-institutional trial described the enhancement kinetics as persistent in 45% of lesions that proved to be cancers (12) .
Type II is a plateau pattern, in which an initial increase in signal intensity is followed by a flattening of the enhancement curve (Fig 4) . This pattern has a sensitivity of 42.6% and specificity of 75% for the detection of malignancy (6) .
Type III, a washout enhancement pattern, involves an initial increase and subsequent decrease in signal intensity (Figs 5, 6 ). This pattern is not usually seen in patients with benign lesions (specificity, 90.4%), but it has a sensitivity of only 20.5% (6) . Schnall et al reported that 76% of curves that showed a washout pattern were associated with cancer. Both type II and type III curves should be considered suggestive of malignancy.
The specificity of breast MR imaging is improved when both morphologic and kinetic features are considered in the interpretation (20) . Because of the overlap in enhancement characteristics between benign and malignant lesions, reliance on a kinetics assessment alone is not recommended. The exclusion of cancer on the basis of persistent enhancement (a type I curve) alone would lead to false-negative results (12) . The quantitative features most indicative of cancer were reported to be the maximum enhancement rate (percentage of enhancement per second) and the percentage of enhancement at 1 minute (12), with rapid enhancement being characteristic of a malignancy.
Imaging Technique
Various MR imaging protocols may be used to obtain breast images of acceptable quality. Most studies reported in the literature were performed at 1.5 T; fewer, at 1.0 T. A standard protocol includes a T2-weighted rapid (fast or turbo) spinecho (repetition time msec/echo time msec, 4000/ 90; section thickness, Յ4 mm) acquisition and three-dimensional T1-weighted GRE (20/4.5; flip angle, 30°-45°; section thickness, Յ3 mm) acquisitions before and after the intravenous administration of contrast material, with the usual dose of 0.1 mmol/kg injected as a bolus and often fol-lowed by a 10 -20-mL saline flush (injected manually or with a power injector). For breast imaging in the sagittal plane, an image matrix of 256 ϫ 192 can be used with zero-filled interpolation to 512 ϫ 512, a small field of view (16 -18 cm), and chemical fat suppression. For bilateral axial breast imaging, the field of view is increased to approximately 30 cm, and high-resolution matrices (between 256 and 512) are used to reduce the voxel size.
Dedicated Breast Surface Coils
A dedicated breast surface coil should always be used. Both unilateral and bilateral coils are commercially available. Unilateral breast MR imaging typically is performed when only a two-channel coil is available; one breast can be imaged on one day, and the patient may return the next day for imaging of the contralateral breast. Most contemporary breast coils have a multicoil phased-array configuration that has been optimized for bilateral imaging of the breasts, chest wall, and axillae. Bilateral breast MR imaging is currently performed with four-channel and eight-channel coils (16-channel coils are expected to be available in the near future), with signal-to-noise improvements resulting from the higher number of channels. Bilateral imaging has the advantage of being quicker and more convenient for the patient. It also allows direct comparison between the two breasts in one field of view, thereby facilitating the assessment of symmetry during screening. However, higher spatial resolution can be obtained with unilateral breast imaging, because, for a given image matrix size, in-plane spatial resolution increases with a reduction in the field of view. It is important to select the right-to-left and superior-to-inferior directions as the phase-encoding direction for axial and sagittal acquisitions, respectively, to reduce motion artifacts. Most coils are open at the side to allow lateral access for intervention and are equipped with a compression plate. The advantages of breast compression during imaging-guided biopsy are minimization of patient motion, decreased thickness of the breast, and shorter imaging time. However, excessive compression may compromise the enhancement of breast tumors, leading to a false-negative result (21) ; therefore, only minimal or no compression should be applied to immobilize the breast during routine breast MR examinations.
Contrast Enhancement
Most tumors can be detected only after intravenous contrast material administration. High-resolution T1-weighted images without or with fat saturation, with thin sections and no gap, are obtained for optimal sensitivity. These requirements are readily achieved by applying three-dimensional GRE sequences with an acquisition time of less than 2 minutes. Rapid imaging allows the application of several contrast-enhanced sequences in a single examination for simultaneous analysis of both the morphologic features and the enhancement kinetics of lesions. It is important to achieve optimal contrast between breast lesions and the surrounding glandular and fatty tissue; therefore, subtraction of unenhanced images from contrast-enhanced images is crucial. Morphologic features (Figs 7-9 ) are best evaluated on highspatial-resolution images; thus, the acquisition of thin sections and the use of a small field of view are recommended (22) . An analysis of architectural features can be performed at any point during the first 4 minutes 30 seconds after the contrast material injection (23) .
Trade-off between Spatial and Temporal Resolution
With increased spatial resolution (with an imaging matrix of 512 ϫ 512) and decreased temporal resolution, the depiction of subtle morphologic details improves significantly, and improved depiction of breast lesions leads to an increase in diagnostic accuracy. There is some loss of kinetic information regarding enhancement rates (eg, the wash-in rate within the first 1-2 minutes), but, compared with morphologic features, enhancement rates are a weaker diagnostic criterion for a finding of malignancy. However, kinetic information regarding the enhancement time-course and enhancement pattern is preserved with acquisition times of 2 minutes or less (22) .
Interpretation Pitfalls
Excessive Acquisition Time.-If the contrastenhanced imaging time is longer than 2 minutes and the first contrast-enhanced images are obtained too late after peak enhancement, washout may no longer be depicted in the descending part of the signal intensity-time curve.
Excessive Size and Incorrect Placement of an ROI.-An ROI of optimal size covers only part of the lesion and should be placed in the region of strongest enhancement on the first contrastenhanced image, a feature that is most clearly distinguishable on color maps of the maximum slope of enhancement. When an ROI is randomly placed in the mass, the enhancement curve may be variable and yield lower specificity (Fig 10) .
Complex Imaging Findings (Physiologic or
Postoperative Changes).-Areas of normal parenchyma in premenopausal women may appear focally enhanced, a feature that may lead to a false-positive finding. Transiently enhancing foci have been observed in the breasts of many healthy women, especially during the second half of the menstrual cycle. Therefore, to minimize false-positive results, breast imaging should be performed during the first half of the menstrual cycle (days 3-14) (24).
In the evaluation of small lesions, the use of multiplanar coordinates allows precise localization of masses and correlation between contrastenhanced images and T2-weighted images ( Fig  10) . Otherwise, small masses may be difficult to map on images obtained with the different sequences. Color-coded map of the maximum slope of enhancement shows that peak enhancement was off center and not covered by the ROI that was selected in the center of the mass. (d) Enhancement curve for the ROI in c shows a type II pattern. The vertical axis indicates the percentage of enhancement, and the horizontal axis indicates the time in seconds. (e) Color-coded map of the maximum slope of enhancement shows the ROI repositioned in the area of peak enhancement. (f) Enhancement curve for the ROI in e shows a type III washout pattern. The vertical axis indicates the percentage of enhancement, and the horizontal axis indicates the time in seconds. For the assessment of enhancement kinetics, it is important to select an ROI in the portion of the tumor with maximum peak enhancement. When an ROI is randomly placed in a mass, the enhancement curve may be variable and yield lower specificity.
Breast MR imaging for the postoperative assessment of residual disease should be performed 28 days or more after surgery (25) . The time interval between surgery and MR imaging of the breast has the greatest influence on the specificity and NPV of MR imaging, which increase progressively over time. However, patients with positive surgical margins whose further surgery should not be delayed may benefit from immediate postoperative MR imaging to determine the distance of disease extension from the surgical site. Future research will provide more data about optimal postoperative management. Postoperative sites may appear enhanced up to 6 months after surgery without radiation therapy and up to 18 -24 months after radiation therapy (5) . MR imaging may not be useful for excluding small foci of residual disease, but it may be helpful for identifying gross residual disease or unsuspected multifocality or multicentricity of disease. Findings suggestive of residual tumor include thickening beyond 5 mm of the enhanced wall of the seroma, and an irregular or nodular enhanced rim around the resection cavity (25) . Lack of enhancement at the lumpectomy site does not obviate reexcision if the surgical margin is positive.
Indications for Breast MR Imaging
Several indications for contrast-enhanced breast MR imaging have been identified and evaluated (5) . MR imaging is useful for screening of selected patient populations and for problem solving, therapy planning, and follow-up. For screening, breast MR imaging is used in patients with a high risk of breast cancer (BRCA1 or BRCA2 mutation carriers), a strong family history of breast cancer, or a condition that may impair mammographic interpretation (eg, silicone or nonsilicone breast augmentation or radiographically dense breasts). In women with a familial risk of breast cancer (lifetime risk of 20% or more), MR imaging was shown to have the highest sensitivity, specificity, and PPV for the detection of invasive as well as of intraductal cancer when compared with mammography and breast US (26) . MR imaging may be performed for contralateral breast screening in women who are newly diagnosed with breast cancer, to search for an occult primary lesion in women with axillary metastases, and in women with previous biopsy-proved atypia or lobular carcinoma in situ. MR imaging may be used for diagnostic work-up in patients with problematic mammograms, especially for lesions seen on only one view, to determine the local extent of malignancy and chest wall involvement, and for preoperative staging. The size of the primary tumor and the presence of multifocal or multicentric disease are important considerations when breast-conserving therapy is planned. After lumpectomy, MR imaging may be performed to identify any residual disease, especially when a positive margin was detected at histopathologic analysis. MR imaging also has been used to assess the response to neoadjuvant chemotherapy. In patients with histologically proved invasive lobular carcinoma, MR imaging is helpful for evaluating the extent, multifocality, and multicentricity of disease, features that are difficult to assess with a physical examination or mammography. In patients with histologically proved infiltrating ductal carcinoma, particularly those who desire breastconserving therapy, MR imaging may be used to evaluate the extent of disease. In those for whom mastectomy is being considered, MR imaging may be used to determine whether chest wall invasion is present. MR imaging may play a role in ongoing disease management, when recurrence is suspected, and when clinical and mammographic findings are inconclusive, or when there is a recurrence of breast cancer in a patient with postoperative tissue reconstruction (eg, with tissue transfer flaps). Another important indication for MR imaging is to differentiate between postoperative scar tissue and recurrent tumor.
Future Developments
Novel MR imaging methods that have the potential to improve specificity for the identification of breast malignancy include multiparametric MR imaging, proton MR spectroscopic imaging, and sodium (Na-23) MR imaging. When used in combination, these techniques provide a comprehensive data set that has far better potential for increasing the accuracy of diagnosis of breast disease than would any single measure. A combination of MR imaging, MR spectroscopy, and sodium MR imaging parameters may be examined in a single MR study (9, 10) . Multiparametric MR imaging (with unenhanced T1-weighted, T2weighted, and contrast-enhanced T1-weighted sequences), combined with MR spectroscopic imaging or sodium MR imaging and advanced computer-aided methods such as the iterative self-organizing data analysis (ISODATA) algorithm, can greatly assist the radiologist in the detection and classification of breast lesions (27) .
The combination of these different MR imaging techniques allows the integration of molecular imaging data with diagnostic imaging data. MR spectroscopic imaging can depict changes in the concentration of intracellular metabolites such as choline, a recognized marker for malignant tissue (28) or increased membrane turnover. Investigators in several studies have demonstrated the detectability of choline in malignant breast lesions with the use of single-voxel proton MR spectroscopy (29) and with multivoxel spectroscopy (10, 30) . A high choline concentration appears to be the spectroscopic hallmark not only of breast cancer but also of human brain tumors, and some investigators have reported a correlation between the tumor grade and choline concentration (31) . High choline concentrations also are considered a marker for prostate cancer (32) and head and neck cancers (33) . Sodium is abundant in most tissues and is actively pumped out of healthy cells by Na ϩ -H ϩ -adenosine triphosphatase, which maintains a large difference in sodium concentration across the cell membrane at the cost of energy-rich adenosine triphosphate. An increase in the total sodium concentration in tissue may be indicative of compromised cellular membrane integrity, impaired energy metabolism, or increased interstitial space through a change in cellular organization or an increase in the vascular volume, all of which are observed in tumors. Tumor growth is accompanied by a change in Na ϩ -H ϩ exchange kinetics, which is part of the signaling mechanism that initiates cell division, and sometimes also by an impaired energy metabolism. The resultant increase in intracellular sodium adds to the increase in the total sodium concentration because of increased interstitial space and neovascularization. The sodium exchange across the cell membrane also may be altered by changes in intra-or extracellular pH, as Figure 11 . Invasive lobular carcinoma in a 43-year-old woman. Multiparametric ISODATA cluster analysis map shows overlap of sodium and proton MR spectroscopic data corresponding to the enhanced mass. In A., the contrastenhanced image shows a heterogeneously enhanced mass with irregular margins. B., Metabolite maps of water, choline, and lipids. C., Sodium MR image and corresponding ISODATA feature map. Spectra show a choline concentration of 3.2 ppm with a signal-to-noise ratio of 10.6 and an approximately 50% increase in the tissue sodium concentration in the region of pathologically proved cancer. those affect the activity of the Na ϩ -H ϩ exchange proteins. Typically, intracellular acidification is a by-product of a failure of the energy metabolism, and it causes the augmentation of influx of sodium due to reduced Na ϩ -H ϩ -adenosine triphosphatase activity. The intracellular sodium cannot be imaged separately from the extracellular sodium concentration without the use of sophisticated MR methods. However, the total sodium concentration in tissue can be resolved by using MR imaging (34, 35) . The ISODATA approach allows the superimposition of a map of combined choline and sodium concentrations over the enhancing breast tissue to enable a characterization of breast lesions, as illustrated in Figure 11 .
Summary
In classifying breast lesions, the assessment of margin and qualitative enhancement intensity (at 2 minutes or less after contrast material injection) are the most important features currently available for breast mass characterization. The next most important feature is the qualitative assessment of the enhancement kinetics curve. The absence of enhancement is associated with an NPV of 88% for cancer. The relative risk of cancer for a lesion that has a washout curve is five times higher than that for a lesion that has a persistent curve. However, a persistent kinetics curve was reported in 45% of malignant lesions (12) . The specificity of breast MR imaging is improved when both morphologic and kinetic features are considered in the image interpretation; therefore, the breast MR imaging technique should be optimized to achieve high spatial and temporal resolution.
